Cargando…
Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor pr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601172/ https://www.ncbi.nlm.nih.gov/pubmed/28948004 http://dx.doi.org/10.18632/oncotarget.19610 |
_version_ | 1783264342090711040 |
---|---|
author | Gou, Qian Gong, Xin Jin, Jianhua Shi, Juanjuan Hou, Yongzhong |
author_facet | Gou, Qian Gong, Xin Jin, Jianhua Shi, Juanjuan Hou, Yongzhong |
author_sort | Gou, Qian |
collection | PubMed |
description | Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor progression in various tissues. Although each PPAR isotype suppresses or promotes tumor development depending on the specific tissues or ligands, the mechanism is still unclear. In this review, we summarized the regulative mechanism of PPARs on cancer progression. |
format | Online Article Text |
id | pubmed-5601172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56011722017-09-25 Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy Gou, Qian Gong, Xin Jin, Jianhua Shi, Juanjuan Hou, Yongzhong Oncotarget Review Peroxisome-proliferator-activated receptors (PPARs) are nuclear hormone receptors including PPARα, PPARδ and PPARγ, which play an important role in regulating cancer cell proliferation, survival, apoptosis, and tumor growth. Activation of PPARs by endogenous or synthetic compounds regulates tumor progression in various tissues. Although each PPAR isotype suppresses or promotes tumor development depending on the specific tissues or ligands, the mechanism is still unclear. In this review, we summarized the regulative mechanism of PPARs on cancer progression. Impact Journals LLC 2017-07-27 /pmc/articles/PMC5601172/ /pubmed/28948004 http://dx.doi.org/10.18632/oncotarget.19610 Text en Copyright: © 2017 Gou et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Review Gou, Qian Gong, Xin Jin, Jianhua Shi, Juanjuan Hou, Yongzhong Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy |
title | Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy |
title_full | Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy |
title_fullStr | Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy |
title_full_unstemmed | Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy |
title_short | Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy |
title_sort | peroxisome proliferator-activated receptors (ppars) are potential drug targets for cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601172/ https://www.ncbi.nlm.nih.gov/pubmed/28948004 http://dx.doi.org/10.18632/oncotarget.19610 |
work_keys_str_mv | AT gouqian peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy AT gongxin peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy AT jinjianhua peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy AT shijuanjuan peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy AT houyongzhong peroxisomeproliferatoractivatedreceptorspparsarepotentialdrugtargetsforcancertherapy |